| Higher SES (q1-3) | Lower SES (q4-5) |  |  | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | OPC | OCC | OPC | OCC | Deprivation gapb | |||||||||
 | Survival rates | 95 % CI | % changea | Survival rates | 95 % CI | % changea | Survival rates | 95 % CI | % changea | Survival rates | 95 % CI | % changea | OPC | OCC |
5-year disease specific survival rates | Â | Â | Â | |||||||||||
 Men |  |  |  | |||||||||||
  1981-2009 | 72.5 | 70.6–76.2 |  | 78.5 | 76.2–80.8 |  | 66.6 | 62.9–69.7 |  | 77 | 74.7–79.3 |  | 5.9 (0.9 to 13.3) | 1.5 (−3.1 to 6.1) |
  1981–1995 | 63.8 | 56.6–71.2 | 11.4 (−0.3 to 22.7) | 82.2 | 79.1–85.5 | −7.5 (−14.6 to 0.9) | 60.9 | 54.1–67.7 | 8.3 (−3 to 19.8) | 81.3 | 78.4–84.2 | −9.2 (−15.6 to –2.6) | 2.9 (−11.1 to 17.1) | 0.9 (−5.1 to 7.1) |
  1996-2009 | 75.2 | 70.9–79.3 | 74.7 | 70.9–78.2 | 69.2 | 64.7–73.9 | 72.1 | 68.6–75.8 | 6 (−3 to 14.6) | 2.6 (−4.9 to 9.6) | ||||
 Women |  |  |  | |||||||||||
  1981-2009 | 68 | 62.2–73.8 |  | 77.2 | 74.1–80.3 |  | 64.2 | 57.8–70.6 |  | 77.1 | 74.0–80.2 |  | 3.8 (−8.5 to 16) | 0.1 (−6.1 to 6.2) |
  1981–1995 | 69.9 | 60.1–79.7 | −2.9 (−20 to 14.4) | 80.2 | 75.7–84.5 | −5.4 (−14 to 3.4) | 64.4 | 54.6–74.2 | −0.5 (−18.7 to 17.7) | 81.3 | 77.0–85.6 | −7.5 (−16.4 to 1.3) | 5.5 (−14.1 to 25.1) | −1.1 (−9.9 to 7.5) |
  1996–2009 | 67 | 59.7–74.5 | 74.8 | 70.5–79.1 | 63.9 | 55.5–72.3 | 73.8 | 69.2–78.3 | 3.1 (−12.6 to 19) | 1 (−7.8 to 9.9) |